Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3261501000168112 | Karvatan HCT 300/25 (hydrochlorothiazide 25 mg + irbesartan 300 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3261511000168110 | Karvatan HCT 300/25 tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Karvatan HCT 300/25 tablet, 30 | has TPUU | True | Karvatan HCT 300/25 tablet | Inferred relationship | Some | 1 |
Karvatan HCT 300/25 tablet, 30, blister pack | has TPUU | True | Karvatan HCT 300/25 tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set